Episodes (Page 6)
✨
Ray Stevens explains structural biology-driven drug discovery.
Ray Stevens
✨
Michele Andrasik discusses improving community outreach for clinical trials.
Michele Andrasik
✨
Derrell Porter shares a new approach to commercializing cell therapies.
Derrell Porter
✨
Praveen Tipirneni explains targeting integrins with small molecules.
Praveen Tipirneni
✨
Bassil Dahiyat on antibody engineering advancements at Xencor.
Bassil Dahiyat
✨
Vineeta Agarwala on investing in health tech and therapeutics.
✨
Nello Mainolfi discusses targeted protein degraders at Kymera.
Nello Mainolfi
✨
Jeff Bluestone on engineered T-reg cell therapies for autoimmunity.
Jeff Bluestone
✨
Ken Song on RayzeBio's targeted radiopharmaceuticals for cancer.
Ken Song
✨
David Baltimore reflects on his extensive career in science.
David Baltimore Reflects
✨
Tony Kulesa on fostering founder-led biotech companies at Petri.bio.
Tony Kulesa
✨
Christian Henry on PacBio's long-read DNA sequencing technology.
Christian Henry
✨
Keolu Fox discusses genome sequencing of indigenous populations.
✨
Mara Aspinall on the role of diagnostics in public health.
Mara Aspinall
✨
John Evans on Beam Therapeutics' base editing technology.
John Evans
✨
Episode: Ep96: Julie Grant and Sam Blackman on Cancer Drugs for Kids
Julie Grant
Sam Blackman
✨
Sue Desmond-Hellmann on her journey as a biotech leader.
Sue Desmond-Hellmann
✨
Jenny Rooke on investing in biotech tools and platforms.
Jenny Rooke
✨
Jay Bradner and Andy Plump on mentoring young scientists.
Jay Bradner
✨
Brad Gray discusses NanoString's spatial biology tools.
Brad Gray